Evidence map›Paper›PMID 32855695›Full record

ArticleExperimental and therapeutic medicine2020

A novel

Yang Liu, Jie Zheng, Li Song, Yulian Fang, Chao Sun, Na Li, Geli Liu, Jianbo Shu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The diagnostic protocol for hereditary spherocytosis-2021 update.Journal of clinical laboratory analysis · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yang LiuDepartment of Neonatalogy, Tianjin Children's Hospital, The Pediatric Clinical College in Tianjin Medical University, Tianjin 300074, P.R. China.
Jie ZhengGraduate College of Tianjin Medical University, Tianjin 300070, P.R. China.
Li SongDepartment of Neonatalogy, Tianjin Children's Hospital, The Pediatric Clinical College in Tianjin Medical University, Tianjin 300074, P.R. China.
Yulian FangTianjin Key Laboratory of Prevention and Treatment of Birth Defects, Tianjin 300134, P.R. China.
Chao SunDepartment of Neonatalogy, Tianjin Children's Hospital, The Pediatric Clinical College in Tianjin Medical University, Tianjin 300074, P.R. China.
Na LiDepartment of Neonatalogy, Tianjin Children's Hospital, The Pediatric Clinical College in Tianjin Medical University, Tianjin 300074, P.R. China.
Geli LiuDepartment of Pediatrics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
Jianbo ShuTianjin Key Laboratory of Prevention and Treatment of Birth Defects, Tianjin 300134, P.R. China.
Tianjin Medical University · CNTianjin Children's Hospital · CNTianjin Medical University General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to enhance the understanding of the diagnosis and treatment of neonatal hereditary spherocytosis (HS). Gene sequencing and analysis was performed for the crucial splicing signals on the exons and introns of the 302 known pathogenic genes [including

Indexed as

hereditary spherocytosisneonatenovel mutationβ-spectrin

Identifiers

PMID32855695
PMCPMC7444424
OpenAlexW3045499663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.